Address
Email addresses
Phone numbers
https://sbd.eeSolis BioDyne | Life Science Reagents | Personal serviceWe offer top quality molecular biology reagents that are all stable at room temperature!
Name
NovoTar Biotech OÜ
Registry code
11349409
VAT number
EE101202202
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
02.03.2007 (17)
Financial year
01.01-31.12
Capital
2 877.00 €
Activity
72111 - Research and experimental development on biotechnology
0 €
-4 618 €
-
-
101 351 €
0
Submitted
No tax arrears
-5%
-5%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Olev Kahre 06.10.1965 (59) | 33% - 959.00 EUR | Board member | Direct ownership | Founder |
| Kadri Artma 23.04.1970 (54) | 33% - 959.00 EUR | Board member | Direct ownership | |
| Agu Artma 05.02.1967 (57) | - | - | - | Founder |
| 2019 18.10.2020 | 2020 14.05.2021 | 2021 24.04.2022 | 2022 21.04.2023 | 2023 02.05.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 150 630 € | 222 650 € | 241 325 € | 57 900 € | 0 € |
| Net profit (loss) for the period | 14 031 € | 65 821 € | 22 202 € | 1 996 € | -4 618 € |
| Profit Margin | 9% | 30% | 9% | 3% | - |
| Current Assets | 61 694 € | 126 776 € | 104 398 € | 105 974 € | 101 356 € |
| Fixed Assets | - | - | - | - | - |
| Total Assets | 61 694 € | 126 776 € | 104 398 € | 105 974 € | 101 356 € |
| Current Liabilities | 744 € | 5 € | 425 € | 5 € | 5 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 60 950 € | 126 771 € | 103 973 € | 105 969 € | 101 351 € |
| Employees | 0 | 0 | 0 | 0 | 0 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | - | - | - |
| 2023 Q4 | - | - | - | - |
| 2023 Q3 | - | - | - | - |
| 2023 Q2 | 82 400 € | - | - | - |
| 2023 Q1 | - | - | - | - |
| 2022 Q4 | - | - | - | - |
| 2022 Q3 | - | - | - | - |
| 2022 Q2 | - | - | - | - |
| 2022 Q1 | 80 010 € | 12 000 € | - | - |
| 2021 Q4 | 27 640 € | 4 528 € | - | - |
| 2021 Q3 | 95 625 € | 6 780.2 € | - | - |
| 2021 Q2 | 70 080 € | 24 116 € | - | - |
| 2021 Q1 | 25 870 € | 5 174 € | - | - |
| 2020 Q4 | 90 450 € | 11 178 € | - | - |
| 2020 Q3 | - | 7 360 € | - | - |
| 2020 Q2 | 82 450 € | 10 920 € | - | - |
| 2020 Q1 | 86 230 € | 15 811 € | - | - |
